The acquisition signals strategic expansion into the EU medical cannabis market, which could drive long-term revenue growth. Traders should monitor integration progress and any updates on the contingent $2 million payment. The use of stock in consideration limits near-term cash burn but introduces modest dilution.
Price Chart
Executive Summary
Aurora Cannabis acquired 100% of EU GMP-certified cannabis cultivator and manufacturer Safari Flower Company for $26.5 million in a mix of cash and stock. The deal, funded with $15 million in cash and 2,417,180 common shares, expands Aurora's European footprint and production capacity in a regulated market.
Key Facts
- Aurora Cannabis indirectly acquired 100% of Safari Flower Company on April 14, 2026
- Aggregate consideration valued at $26.5 million, including $15 million in cash paid at closing and 2,417,180 Aurora common shares issued
- An additional $2 million in cash is contingent on certain conditions being met
- Safari Flower Company is an EU GMP-certified cannabis cultivator and manufacturer
- The acquisition is expected to enhance Aurora's European market access and regulated production capabilities
Financial Impact
$26.5 million total deal value, with $15 million in immediate cash outlay and stock issuance diluting existing shareholders by approximately 1.2% based on ACB's $209M market cap
Risk Factors
- Integration risk of Safari Flower Company into Aurora's operations
- Contingent $2 million payment could increase total cost if conditions are met
- EU regulatory or market adoption risks for medical cannabis
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001279569-26-000312 |
| Document: aurora_6k.htm | 0001279569-26-000312 |
| Document: 0001279569-26-000312-index-headers.html | 0001279569-26-000312 |
| Document: 0001279569-26-000312-index.html | 0001279569-26-000312 |
| Document: 0001279569-26-000312.txt | 0001279569-26-000312 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | $3.87 | awaiting T+5 | — | $3.90 (+0.78%) |
Oct 14, 2026 12d ago | 6-K | $4.10 $3.97 | ▼ −3.17% | ▼ −2.16% | $3.90 (−4.88%) |
Oct 8, 2026 18d ago | 6-K | $4.43 $4.10 | ▼ −7.45% | ▼ −7.17% | $3.90 (−11.96%) |
Oct 6, 2026 20d ago | 6-K | $4.46 $4.17 | ▼ −6.50% | ▼ −5.52% | $3.90 (−12.56%) |
Oct 5, 2026 20d ago | 6-K | $4.59 $4.29 | ▼ −6.54% | ▼ −6.40% | $3.90 (−15.03%) |
Sep 16, 2026 5w ago | 6-K | $3.83 $4.22 | ▲ +10.18% | ▲ +7.62% | $3.90 (+1.83%) |
Sep 14, 2026 6w ago | 6-K | $3.81 $4.03 | ▲ +5.77% | ▲ +5.67% | $3.90 (+2.36%) |
Sep 9, 2026 6w ago | 6-K | $3.88 $3.83 | ▼ −1.29% | ▼ −0.63% | $3.90 (+0.52%) |
Sep 2, 2026 7w ago | 6-K | $4.03 $3.73 | ▼ −7.44% | ▼ −6.49% | $3.90 (−3.23%) |
Aug 24, 2026 9w ago | 6-K | $3.94 $4.05 | ▲ +2.79% | ▲ +2.32% | $3.90 (−1.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers